MedTrace Logo

Joint Replacement or Interpositional Arthroplasty for CMC1 Arthritis, a Prospective Trial

NCT02556515 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2018-09-25

No results posted yet for this study

Summary

Interpositional arthroplasty is by many considered to be the current gold standard for the treatment of thumb carpometacarpal arthritis. The results are generally good, but the rehabilitation time can be long and failures are difficult to treat. Total joint replacements now exist with modern uncemented designs that can be an alternative treatment. Short term studies show that thumb function often is better and rehabilitation time shorter, however there is uncertainty with regards to the longevity of the implants. Currently no prospective randomized trials have compared these two treatment options. Our hypothesis is that the total joint replacement will give the same results or better when compared to the interpositional arthroplasty.

Conditions

  • Osteoarthrosis of the Carpometacarpal Joint of the Thumb

Interventions

PROCEDURE

Interpositional arthroplasty (Burton-Pellegrini procedure)

Burton-Pellegrini procedure

PROCEDURE

Total joint replacement

Total joint replacement

DEVICE

Elektra prosthesis

Elektra prosthesis

Sponsors & Collaborators

  • Oslo University Hospital

    lead OTHER

Principal Investigators

  • Rasmus Thorkildsen, MBBS(Bsc) · Hand- and microsurgical unit, Oslo University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-11-24
Primary Completion
2018-03-16
Completion
2018-03-16

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02556515 on ClinicalTrials.gov